A Study to Assess the Steady-State Bioequivalence of Once-Weekly Corplex™ 10mg Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept®
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics; Registrational
- Sponsors Corium International
- 16 Nov 2017 According to a Corium International media release, the first treatment period will be complete in December.
- 27 Oct 2017 Planned number of patients changed from 60 to 86.
- 27 Oct 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Mar 2018.